Literature DB >> 23045141

Toxicology testing in drug discovery and development.

Michael A Dorato1, Lorrene A Buckley.   

Abstract

The primary objective of toxicology studies in the drug discovery process is to evaluate the safety of potential drug candidates. This is accomplished using relevant animal models and validated procedures. The ultimate goal is to translate the animal responses into an understanding of the risk for human subjects. To this end the toxicologist must be aware of the international guidelines for safety evaluation as well as traditional and nontraditional toxicology models. As described in this unit, the typical toxicology profile consists of safety pharmacology, genetic toxicology, acute and subchronic toxicology, absorption, distribution, metabolism, and excretion (ADME) studies, reproductive and developmental toxicity, and an evaluation of carcinogenic potential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 23045141     DOI: 10.1002/0471141755.tx1901s31

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  3 in total

1.  The HCV Revolution Did Not Happen Overnight.

Authors:  Ann D Kwong
Journal:  ACS Med Chem Lett       Date:  2014-03-13       Impact factor: 4.345

2.  Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone.

Authors:  Laís D Rodrigues; Leandro F Oliveira; Lucas Shinoda; Carla A Scorza; Jean Faber; Henrique B Ferraz; Luiz R G Britto; Fulvio A Scorza
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

3.  Hydrogel Based 3-Dimensional (3D) System for Toxicity and High-Throughput (HTP) Analysis for Cultured Murine Ovarian Follicles.

Authors:  Hong Zhou; Malika Amattullah Malik; Aarthi Arab; Matthew Thomas Hill; Ariella Shikanov
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.